Article Text

Download PDFPDF
E-cigarette users commonly stealth vape in places where e-cigarette use is prohibited
  1. Jessica M Yingst1,
  2. Courtney Lester1,
  3. Susan Veldheer1,
  4. Sophia I Allen1,
  5. Ping Du1,2,
  6. Jonathan Foulds1
  1. 1 Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA
  2. 2 Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA
  1. Correspondence to Jessica M Yingst, Public Health Sciences, Penn State College of Medicine, Hershey PA 17033, USA; jyingst{at}phs.psu.edu

Footnotes

  • Contributors JMY completed the data analysis and drafted the manuscript. CL, SV, SIA, PD and JF discussed the concept of the manuscript and reviewed the drafted manuscript.

  • Funding The authors are partly supported by the National Institute on Drug Abuse of the National Institutes of Health and the Center for Tobacco Products of the US Food and Drug Administration (under award number P50-DA-036107). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.

  • Competing interests JF has done paid consulting for pharmaceutical companies involved in producing smoking cessation medications, including GSK, Pfizer, Novartis, J&J and Cypress Bioscience, and received a research grant from Pfizer. There are no competing interests to declare for other authors.

  • Patient consent Obtained.

  • Ethics approval This study was approved by the Penn State University College of Medicine Institutional Review Board, Hershey.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors JMY completed the data analysis and drafted the manuscript. CL, SV, SIA, PD and JF discussed the concept of the manuscript and reviewed the drafted manuscript.

  • Funding The authors are partly supported by the National Institute on Drug Abuse of the National Institutes of Health and the Center for Tobacco Products of the US Food and Drug Administration (under award number P50-DA-036107). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.

  • Competing interests JF has done paid consulting for pharmaceutical companies involved in producing smoking cessation medications, including GSK, Pfizer, Novartis, J&J and Cypress Bioscience, and received a research grant from Pfizer. There are no competing interests to declare for other authors.

  • Patient consent Obtained.

  • Ethics approval This study was approved by the Penn State University College of Medicine Institutional Review Board, Hershey.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.